- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07442318
Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia (ENABLE)
Enhancing Non-Communicable Disease Prevention Among Pregnant Women Through Healthy Lifestyle Promotion in Four Urban Sites in Ethiopia: A Cluster Randomized Controlled Trial in Primary Health Care Facilities
The ENABLE study focuses on pregnant women attending routine antenatal care (ANC) in urban primary health care facilities in four Ethiopian cities. Many women in this setting face increased health risks due to unhealthy diets, low physical activity, and exposure to air pollution which can affect both maternal and newborn health and increase the risk of non-communicable diseases (NCDs) later in life.
In this study, pregnant women in intervention health centers receive structured, tailored counseling as part of their regular ANC visits. This counseling supports healthier eating, physical activity and reduced exposure to air pollution. Health care providers, including health workers in health centers and Urban Health Extension Professionals (UHEPs), are trained to deliver this counseling supported by a digital ANC eRegistry for clinical decision-making, which enhances adherence to national guidelines, and strengthens the quality of care. Facilitators further strengthen the intervention's implementation by ensuring fidelity to counseling protocols and by adapting content to the Ethiopian urban health system context.
The study hypothesis is that integrating lifestyle counseling into routine ANC will improve maternal health behaviors and pregnancy outcomes, and reduce NCD risk among pregnant women, compared with standard routine ANC alone.
By embedding NCD prevention within routine maternal health services, the ENABLE study aims to strengthen the role of ANC as a platform for early prevention and long-term health benefits for women and their children.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The ENABLE study is a two-arm, parallel-group, cluster-randomized controlled trial (cRCT) designed to address the rising burden of NCDs in Ethiopia by integrating NCD risk reduction counseling into routine ANC.
The investigators will evaluate the effectiveness and implementation of an integrated ANC-based intervention for reducing NCD risk factors during pregnancy in urban Ethiopia. The trial follows a Hybrid Type II effectiveness-implementation design, simultaneously assessing effectiveness on improving birth outcomes, specifically birth weight, and evaluating implementation processes under routine primary health care conditions.
The study will be conducted in 77 public urban health centers in four Ethiopian cities: Addis Ababa, Adama, Harar, and Jimma. Health centers and their catchment areas constitute the unit of randomization (clusters)," and are allocated in a 1:1 ratio to the intervention or control arm using covariate-constrained randomization to ensure balance by facility size and baseline ANC caseload. The trial will enroll 1,268 pregnant women (approximately 19 per cluster) who are attending their first routine ANC visit at ≤20 weeks of gestation. The women will be followed up through delivery.
The ENABLE intervention integrates structured counselling on three modifiable NCD risk factors, namely unhealthy diet, physical inactivity, and exposure to air pollution, into routine ANC services. The intervention is designed to be delivered within existing health care delivery systems by health workers and UHEPs within routine service workflows. Counseling follows the WHO 5As behavior change model (Ask, Advise, Assess, Assist, Arrange) which is based on WHO's brief intervention ("BRIEF project"), national ANC guidelines, and other relevant national recommendations and has been adapted to the local context.
Based on previous knowledge and formative work, the intervention is implemented through three tailored implementation strategies:
i) Facilitation: Trained facilitators provide ongoing support and collaborative problem-solving around intervention delivery to health workers and UHEPs to strengthen counseling skills and ensure fidelity to the intervention.
ii) Digital ANC eRegistry: A digital tool, adapted from the WHO Digital Adaptation Kit, supports standardized screening, clinical decision support, documentation, automates SMS reminders for patients, and routine monitoring of service quality and outcomes at the point of care.
iii) Training: Health workers in intervention facilities receive targeted training on NCD risk screening, counseling delivery, and use of the digital ANC eRegistry to promote sustainable integration of NCD prevention within routine maternal health services.
Health centers randomized to the control arm continue to provide standard routine ANC according to national guidelines, without access to ENABLE training, facilitation or the digital ANC eRegistry.
The primary effectiveness outcome is newborn birth weight. Other outcomes include maternal dietary quality, physical activity, behaviors related to indoor air pollution exposure, and quality of ANC service delivery and NCD-related screening and counseling practices. Implementation outcomes include feasibility, acceptability, appropriateness, fidelity, and contextual determinants of implementation. Data are collected using structured surveys, routine digital records, and qualitative methods (focus group discussions and interviews).
Additionally, a biomarker sub-study will examine early-life biological pathways associated with early NCD risks by analyzing maternal and newborn blood and urine samples from a subset of participants.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Masresha Tessema, PhD
- Phone Number: +251919782082
- Email: dr.masresha.tessema@gmail.com
Study Contact Backup
- Name: Jerusalem Belay, MSc
- Phone Number: +251909647171
- Email: jerusalembelay1207@gmail.com
Study Locations
-
-
Addis Ababa
-
Addis Ababa, Addis Ababa, Ethiopia
- Recruiting
- Addis Ababa
-
Contact:
- Masresha Tessema
- Phone Number: +251 11 213 3499
- Email: dr.masresha.tessema@gmail.com
-
Principal Investigator:
- Masresha Tessema
-
-
Harare
-
Harar, Harare, Ethiopia
- Recruiting
- Harar
-
Contact:
- Kedir Roba
- Phone Number: +251 025 666 1881
- Email: kedir.t.roba@gmail.com
-
Principal Investigator:
- Kedir Roba
-
-
Oromiya
-
Jimma, Oromiya, Ethiopia
- Recruiting
- Jimma
-
Contact:
- Gudina Terefe
- Phone Number: +251 094 120 5177
- Email: gudina.terefe@ju.edu.et
-
Principal Investigator:
- Gudina Terefe
-
Ādama, Oromiya, Ethiopia
- Recruiting
- Adama
-
Contact:
- Hanna Berhane
- Phone Number: +251 11 639 0000
- Email: hannayemane@addiscontinental.edu.et
-
Principal Investigator:
- Hanna Berhane
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women aged 18 years or older
- Gestational age ≤20 weeks at the time of enrollment
- Residing in one of the four study cities (Addis Ababa, Adama, Harar, or Jimma)
- Attending their first antenatal care visit at one of the participating public health facilities
- Willing and able to provide informed consent
Exclusion Criteria:
- Pregnant women identified as high risk at enrollment, including those with pre-existing medical conditions, or other conditions requiring specialized care and who cannot continue receiving standard routine ANC.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ENABLE Intervention arm
Pregnant women in the intervention arm receive antenatal care (ANC) at health centers implementing the ENABLE intervention.
In addition to routine ANC, health workers in health centers allocated to this arm integrate structured counseling on three modifiable non-communicable disease (NCD) risk factors during pregnancy, supported by implementation strategies.
Participants are followed from enrollment through delivery, with outcome data collected during routine care and scheduled study assessments.
|
The intervention is delivered throughout pregnancy beginning at enrollment. The intervention is implemented through three context tailored strategies: health worker training, facilitation, and a digital ANC eRegistry. The ENABLE intervention integrates structured counseling on three modifiable non-communicable disease (NCD) risk factors into routine antenatal care (ANC), to promote healthy dietary behaviors, physical activity, and behaviors related to exposure to air pollution during pregnancy, aiming to improve maternal and newborn outcomes. Facility and community-based health workers counsel pregnant women during scheduled ANC visits and through community outreach contacts by Urban Health Extention Proffesionals (UHEPs). |
|
Active Comparator: Control arm
Pregnant women in the control arm receive standard routine antenatal care (ANC) according to the Ethiopian national guidelines at health centers assigned to the control group.
Unlike the intervention group, the control group does not receive the ENABLE multicomponent package, therefore health workers at these health centers are not provided with ENABLE facilitator-supported counseling, training or digital tools.
Participants are followed from enrollment through delivery, with outcome data collected during standard routine care and scheduled study assessments.
|
Standard routine antenatal care (ANC) as defined by the Ethiopian national ANC guidelines.
This includes standard clinical assessments, counseling and follow-up provided during pregnancy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Birth weight
Time Frame: At delivery (within 24 hours)
|
Birth weight of the newborn measured in grams within 24 hours of delivery using calibrated scales and recorded in the routine register or digital ANC eRegistry.
|
At delivery (within 24 hours)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary Behavior
Time Frame: Baseline (enrollment) and third trimester of pregnancy (≥28 weeks of gestation)
|
Dietary behaviors are assessed using diet quality indicators, including dietary diversity score, minimum dietary diversity for women (MDD-W), Global Dietary Recommendation (GDR) score, NCD risk scores measured by the Diet Quality Questionnaire.
In a subsample of participants selected for biomarker collection, multiple-pass 24-hour dietary recalls will be conducted to derive Global Diet Quality Score, adherence to the Ethiopian Food-Based Dietary Guidelines, and mean probability of adequacy of micronutrients based on dietary intake.
In the same subsample, maternal biological samples will be collected and analyzed for selected biochemical markers of micronutrient deficiencies.
|
Baseline (enrollment) and third trimester of pregnancy (≥28 weeks of gestation)
|
|
Physical activity
Time Frame: Baseline (enrollment) and third trimester of pregnancy (≥28 weeks of gestation)
|
Physical activity is assessed using self-reported measures of frequency, duration and intensity of activities (both physical activity and sedentary activities) during pregnancy, using the Pregnancy Physical Activity Questionnaire.
In a sub-sample physical activity is additionally assessed using wearable activity monitors to record movement and sedentary time.
|
Baseline (enrollment) and third trimester of pregnancy (≥28 weeks of gestation)
|
|
Air pollution exposure-related behaviors
Time Frame: Baseline (enrollment) and third trimester of pregnancy (≥28 weeks of gestation)
|
Behaviors related to air pollution exposure are assessed using a composite index capturing the adoption of recommended practices to reduce household and environmental air pollution during pregnancy.
In a subsample of participants, household air quality is objectively assessed using air pollution monitoring devices to estimate indoor air pollutant levels.
|
Baseline (enrollment) and third trimester of pregnancy (≥28 weeks of gestation)
|
|
Quality of NCD counseling during ANC
Time Frame: Three occasions, i.e., baseline, and at 12 and 18 months after facilitation has commenced. The last measurement includes a 6-month follow-up after completing the facilitation component.
|
Fidelity to the delivery of the counseling on NCD risk factors during ANC and its perceived quality is assessed through structured surveys with pregnant women attending ANC services in both intervention and control facilities.
Measures capture the content, frequency, and perceived quality of counseling related to diet, physical activity, and air pollution during pregnancy.
|
Three occasions, i.e., baseline, and at 12 and 18 months after facilitation has commenced. The last measurement includes a 6-month follow-up after completing the facilitation component.
|
|
Quality of ANC related to NCDs
Time Frame: Baseline, and at 12 months after implementation has commenced
|
Quality of ANC assessed using routine service delivery indicators reflecting appropriate screening and management of pregnancy-related conditions associated with NCD.
Indicators include the proportion of pregnant women appropriately screened and managed for anemia, gestational diabetes, gestational hypertension, and maternal malnutrition, assessed using mid-upper arm circumference (MUAC) and body mass index (BMI).
Data are derived from routinely collected ANC records in both intervention and control facilities.
|
Baseline, and at 12 months after implementation has commenced
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implementation outcomes of the ENABLE Intervention
Time Frame: 7a-d: Two occasions, i.e., baseline, and at 12 months after facilitation has commenced 7e: 12 months after facilitation has commenced 7f: two occasions, 6 and 12 months after facilitation has commenced
|
Implementation outcomes are assessed among health workers, UHEPs and facilitators involved in delivering the ENABLE intervention.
Outcomes include: a)acceptability of counselling pregnant women on NCD risk factors; b)appropriateness of counselling pregnant women on NCD risk factors; c)feasibility of counselling pregnant women on NCD risk factors; d)contextual factors that may influence the counselling pregnant women on NCD risk factors; e)experiences of of facilitators involved in supporting the ENABLE intervention.
Data are collected through structured surveys and interviews.
|
7a-d: Two occasions, i.e., baseline, and at 12 months after facilitation has commenced 7e: 12 months after facilitation has commenced 7f: two occasions, 6 and 12 months after facilitation has commenced
|
|
Use of digital ANC tool
Time Frame: At 3 months and at 9 months
|
Use of the digital antenatal care tool is assessed among health workers in intervention facilities, including frequency of use, completeness of documentation, and perceived usefulness for clinical decision-making and service delivery.
Data are collected via system logs and health worker surveys.
|
At 3 months and at 9 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Masresha Tessema, PhD, Ethiopian Public Health Institute
- Principal Investigator: Eleni Papadopoulou, PhD, Norwegian Institute of Public Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPHI-IRB-607-2025
- 101137232 (Other Grant/Funding Number: EU)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-communicable Diseases (NCD)
-
University of BarcelonaCatSalut Catalonia, SpainCompletedCardiovascular Risk | Obesity Prevention | Non-communicable Diseases (NCD)Spain
-
University of ThessalyGeneral Hospital of Larissa; General Hospital of Trikala; National Organization... and other collaboratorsRecruitingIncarceration | Non-communicable Diseases (NCD) | Addiction to Opioids | Opioid-use DisordersGreece
-
Columbia UniversityNational Institutes of Health (NIH)CompletedTuberculosis | HIV (Human Immunodeficiency Virus) | AIDS (Acquired Immune Deficiency Syndrome) | Non-communicable Diseases (NCD)Kenya
-
Deraya UniversityNot yet recruitingNon Communicable Diseases | Non Communicable Chronic DiseasesEgypt
-
Medical University of BialystokCompletedNon Communicable DiseasesPoland
-
Beijing Tsinghua Chang Gung HospitalRecruitingLifestyle Intervention | Non Communicable DiseasesChina
-
Chi Research & Infotec Ltd.Directorate General of Health ServicesCompletedNon-communicable Disease Risk FactorsBangladesh
-
Chinese University of Hong KongCompletedHealth Risk Behaviors | Non Communicable DiseasesHong Kong
-
Johns Hopkins Bloomberg School of Public HealthInstitute of Epidemiology, Disease Control and ResearchCompletedSurveys and Questionnaires | Non Communicable DiseasesBangladesh
-
Leiden University Medical CenterUniversity of Edinburgh; Makerere University; Maastricht University; University... and other collaboratorsNot yet recruitingTobacco Use | Pollution; Exposure | Non-communicable Disease